Enanta Pharmaceuticals
ENTA
#8718
Rank
HK$1.82 B
Marketcap
HK$62.60
Share price
-3.04%
Change (1 day)
-33.72%
Change (1 year)

Market capitalization of Enanta Pharmaceuticals (ENTA)

Market cap: HK$1.82 Billion

As of November 2026 Enanta Pharmaceuticals has a market cap of HK$1.82 Billion. This makes Enanta Pharmaceuticals the world's 8718th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Enanta Pharmaceuticals from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$1.82 B-51.82%
2025HK$3.78 B282.65%
2024HK$0.98 B-36.1%
2023HK$1.54 B-79.53%
2022HK$7.55 B-36.78%
2021HK$11.95 B82.46%
2020HK$6.55 B-31.25%
2019HK$9.53 B-11.58%
2018HK$10.77 B22.94%
2017HK$8.76 B77.28%
2016HK$4.94 B2.83%
2015HK$4.81 B-34.48%
2014HK$7.34 B93.17%
2013HK$3.80 B

End of Day market cap according to different sources

On Nov 19th, 2026 the market cap of Enanta Pharmaceuticals was reported to be:

HK$1.82 Billion
by Nasdaq info icon info icon
HK$1.82 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$5.044 T 276,591.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$2.240 T 122,779.61%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
HK$3.931 T 215,539.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$1.035 T 56,696.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$2.568 T 140,769.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$935.46 B 51,208.67%๐Ÿ‡บ๐Ÿ‡ธ USA